Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of Eszopiclone

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Parkinson's DiseaseInsomnia
Interventions
DRUG

eszopiclone

eszopiclone

OTHER

placebo

matching placebo administered at night

Trial Locations (4)

19104

University of Pennsylvania Medical School, Philadelphia

30024

Fusion Sleep Center, Suwanee

08818

The New Jersey Neuroscience Institute, Edison

08854

UMDNJ Robert Wood Johnson Medical School, Piscataway

All Listed Sponsors
collaborator

Sumitomo Pharma America, Inc.

INDUSTRY

lead

University of Medicine and Dentistry of New Jersey

OTHER

NCT00324896 - Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of Eszopiclone | Biotech Hunter | Biotech Hunter